
Dosage Hyper Pharma LLP
About Dosage Hyper Pharma LLP
Data last updated:
Dosage Hyper Pharma LLP is a limited liability partnership (LLP) based in Kondotty, Kerala, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 September 2018 and has been in existence for over 8 years.
The LLP is registered with the Registrar of Companies (ROC), Ernakulam, under LLPIN AAN-3432. Its GSTIN is 32AAPFD3123Q1Z8 (Kerala).
The LLP has a total obligation of contribution of βΉ2.93 Cr. It is led by designated partners Mohammed and Faizal Babu Ambalancheeri.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Room No.9/2290 2291 Near Mdc Bank Bypass Junction, Kondotty, Kerala, India β 673638.
Company details
Contact details
Dosage Hyper Pharma LLP's registered office is in Kondotty, Kerala.
- Registered AddressRoom No.9/2290 2291 Near Mdc Bank Bypass Junction, Kondotty, Kerala, India β 673638
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Dosage Hyper Pharma LLP
FY 2025 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | |||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | |||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Dosage Hyper Pharma LLP, buy the company report.
Designated partners of Dosage Hyper Pharma LLP
Dosage Hyper Pharma has 2 current designated partners and 4 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammed | Designated Partner | 25 Sep 2018 | 8 Years 1 Months | Current |
| Faizal Babu Ambalancheeri | Designated Partner | 10 May 2023 | 3 Years 6 Months | Current |
Legal cases
No court or tribunal cases involving Dosage Hyper Pharma LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dosage Hyper Pharma LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dosage Hyper Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAPFD3123Q1Z8 | Kerala | Active | 02 Nov 2018 |
To see the full GST registrations and return filing status of Dosage Hyper Pharma LLP, buy the company report.
Recent activity
Dosage Hyper Pharma LLP has 7 designated partner changes on record since 2018: 6 appointments and 1 cessation. The latest: Faizal Babu Ambalancheeri was appointed as Designated Partner on 10 May 2023.
Frequently asked questions
Dosage Hyper Pharma is an active limited liability partnership based in Kondotty, Kerala, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 25 September 2018 (8+ years old) and is registered under LLPIN AAN-3432.
Dosage Hyper Pharma has 2 current designated partners:
- Mohammed - Designated Partner
- Faizal Babu Ambalancheeri - Designated Partner
The latest financial statements of Dosage Hyper Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Dosage Hyper Pharma is 32AAPFD3123Q1Z8, registered in Kerala.
The LLPIN (Limited Liability Partnership Identification Number) of Dosage Hyper Pharma is AAN-3432. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Dosage Hyper Pharma was incorporated on 25 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ernakulam.
Faizal Babu Ambalancheeri was appointed as Designated Partner on 10 May 2023. Mohammed Kutty Cholakkal was appointed as Partner on 10 May 2023. Moossakutty ceased to be Designated Partner on 10 May 2023. Dosage Hyper Pharma has 7 designated partner changes on record in total.
The registered office of Dosage Hyper Pharma is at Room No.92290 2291 Near Mdc Bank Bypass Junction, Kondotty, Kerala, India β 673638.
Dosage Hyper Pharma operates in the pharma industry, in the drug formulation and development segment.
Dosage Hyper Pharma can be reached at its registered office: Room No.92290 2291 Near Mdc Bank Bypass Junction, Kondotty, Kerala, India β 673638.

